Dr. Guy James Lefort, MD

Dr. Lefort practices at INTEGRIS Health Miami Hospital - Mammography in Miami, Oklahoma.

Dr. Lefort's NPI, 1821363177, was assigned on March 20, 2012. Dr. Lefort graduated from Louisiana State University School of Medicine in Shreveport in 2012. Dr. Lefort holds Louisiana license MD.206319.

Dr. Lefort's primary practice is INTEGRIS Health Miami Hospital - Mammography, at 200 2nd Ave SW, Miami, OK 74354. The practice phone is (918) 540-7551.

Dr. Lefort's primary practice is INTEGRIS Health Miami Hospital - Mammography in Miami, Oklahoma. Dr. Lefort is also affiliated with Terrebonne General Health System. The medical group on file is Ochsner Health. Dmand AI also links Dr. Lefort to 1 more hospital, 10 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lefort practices, 6 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Lefort's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Lefort is licensed in Louisiana.

CMS data shows 422 Medicare services from Dr. Lefort across 4 procedure codes in 2024, for 378 Medicare patients. Medicare paid $45,623 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 378 Medicare patients who saw Dr. Lefort in 2024. The largest group is 75 to 84, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lefort's median patient age at 41, with 56% women.

In 2024, Dr. Lefort wrote 288 Medicare Part D claims for 184 patients. 96% of them were for generic drugs. CMS names the drug for 143 of them, across 8 drugs with 11 or more claims each, at $791 in total drug cost. In 2023, CMS named 109 claims across 5 drugs.

Dr. Lefort accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Lefort in 2014. Dr. Lefort's most frequent co-authors are Terrell S. Caffery, MD and Claude Marion D'Antonio, MD.

CMS Open Payments shows 117 general payments to Dr. Lefort from 7 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 72% of the total. Inari Medical, Inc. paid the most, $21,481.

Dr. Lefort graduated from Louisiana State University School of Medicine in Shreveport in 2012.